Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
Gállego Pérez-Larraya J, Garcia-Moure M, Labiano S, Patiño-García A, Dobbs J, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, Puigdelloses M, Laspidea V, Astigarraga I, Lopez-Ibor B, Cruz O, Oscoz Lizarbe M, Hervas-Stubbs S, Alkorta-Aranburu G, Tamayo I, Tavira B, Hernandez-Alcoceba R, Jones C, Dharmadhikari G, Ruiz-Moreno C, Stunnenberg H, Hulleman E, van der Lugt J, Idoate MÁ, Diez-Valle R, Esparragosa Vázquez I, Villalba M, de Andrea C, Núñez-Córdoba JM, Ewald B, Robbins J, Fueyo J, Gomez-Manzano C, Lang FF, Tejada S, Alonso MM. Gállego Pérez-Larraya J, et al. Among authors: esparragosa vazquez i. N Engl J Med. 2022 Jun 30;386(26):2471-2481. doi: 10.1056/NEJMoa2202028. N Engl J Med. 2022. PMID: 35767439 Clinical Trial.
RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases.
Puigdelloses M, González-Huárriz M, García-Moure M, Martínez-Vélez N, Esparragosa Vázquez I, Bruna J, Zandio B, Agirre A, Marigil M, Petrirena G, Nuñez-Córdoba JM, Tejada-Solís S, Díez-Valle R, Gállego-Culleré J, Martínez-Vila E, Patiño-García A, Alonso MM, Gállego Pérez-Larraya J. Puigdelloses M, et al. Among authors: esparragosa vazquez i. Neurooncol Adv. 2020 Jan 31;2(1):vdaa010. doi: 10.1093/noajnl/vdaa010. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642678 Free PMC article.
CLIPPERS syndrome: A case report.
Esparragosa Vázquez I, Valentí-Azcárate R, Gállego Pérez-Larraya J, Riverol Fernández M. Esparragosa Vázquez I, et al. Neurologia (Engl Ed). 2020 Nov-Dec;35(9):690-692. doi: 10.1016/j.nrl.2019.11.002. Epub 2020 Jan 22. Neurologia (Engl Ed). 2020. PMID: 31982217 Free article. English, Spanish. No abstract available.
Multiple cerebral microbleeds associated with disseminated intravascular coagulation.
Valenti-Azcarate R, Irimia Sieira P, Esparragosa Vazquez I, Riverol Fernandez M. Valenti-Azcarate R, et al. Among authors: esparragosa vazquez i. Neurologia (Engl Ed). 2021 Jan-Feb;36(1):88-89. doi: 10.1016/j.nrl.2020.01.003. Epub 2020 Mar 12. Neurologia (Engl Ed). 2021. PMID: 32173605 Free article. English, Spanish. No abstract available.
Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia.
Toledano-Illán C, Esparragosa Vázquez I, Zelaya Huerta MV, Rosales Castillo JJ, Paternain Nuin A, Arbizu Lostao J, García de Eulate MR, Riverol Fernández M. Toledano-Illán C, et al. Among authors: esparragosa vazquez i. J Neurol. 2021 Jun;268(6):2256-2258. doi: 10.1007/s00415-021-10484-y. Epub 2021 Feb 26. J Neurol. 2021. PMID: 33635389 No abstract available.
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
Esparragosa Vazquez I, Ndiaye M, Di Stefano AL, Younan N, Larrieu-Ciron D, Seyve A, Picart T, Meyronet D, Boutet C, Vassal F, Carpentier C, Figarella-Branger D, Dehais C, Forest F, Rivoirard R, Ducray F; POLA network. Esparragosa Vazquez I, et al. Eur J Neurol. 2023 Sep;30(9):2879-2883. doi: 10.1111/ene.15873. Epub 2023 May 31. Eur J Neurol. 2023. PMID: 37204066
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.